Home
Conditions
Pancreatic Neoplasms

Clinical trial condition

Pancreatic Neoplasms

Explore clinical trials studying Pancreatic Neoplasms. Study availability and eligibility vary by location and protocol.

2,460 public trials 581 recruiting studies

Refine in advanced search Browse all conditions

Pancreatic Neoplasms trial results

Not Yet Recruiting

Conventional Partial Pancreatoduodenectomy Versus an Extended Pancreatoduodenectomy for Pancreatic Head Cancers

NCT06703905

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Second-line Irinotecan Liposome Combination Regimen for Irinotecan-treated Pancreatic Cancer

NCT06700603

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Multi-center, Single-arm, Prospective Non-interventional Study to Investigate the Safety Profiles and Effectiveness of Liposomal Irinotecan (ONIVYDE®) in Combination with 5-fluorouracil (5-FU) and Leucovorin (LV) in Chinese Patients with Metastatic Pancreatic Cancer As Approval Condition (SEOPAC)

NCT06688240

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Irreversible Electroporation Ablation Combined With Anti-PD(L)1 Therapy for Locally Advanced Pancreatic Cancer

NCT06677762

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

YL-13027 and/or HY-0102 Combined With AG Regimen Chemotherapy for Metastatic Pancreatic Cancer

NCT06662669

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

BGT007 Treatment for Recurrent/refractory Gastrointestinal Malignancies

NCT06645301

Conditions: Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +14 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Anlotinib Plus Benmelstobart and AG in First-line Treatment of Advanced Metastatic Pancreatic Cancer (ALTER-PA-001)

NCT06621095

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +8 more
Locations: Renji hospital Shanghai, Shanghai Municipality, China

View Trial Details

Not Yet Recruiting

TP53 R248Q TCR-T Cell Therapy for Advanced Solid Tumor

NCT06619886

Conditions: Adenocarcinoma, Adenocarcinoma of Lung, Carcinoma, +25 more
Locations: Department of Oncology, Shanghai General Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Not Yet Recruiting

A PARG Inhibitor DAT-2645 Monotherapy in Patients with Advanced/Metastatic Solid Tumors Harboring BRCA1/2 Loss of Function Alterations And/or Other Defects in the DDR Pathway

NCT06614751

Conditions: Advanced Cancer, BRCA Mutation, Breast Cancer, +44 more
Locations: Peking University Cancer Hospital and Institute Beijing, Beijing Municipality, China

Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Beijjing, Beijing Municipality, China

View Trial Details

Not Yet Recruiting

Liposomal Irinotecan in Combination With Oxaliplatin and S-1 Versus Gemcitabine Combined With Capecitabine as Postoperative Adjuvant Therapy for Pancreatic Cancer

NCT06571461

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations: Not specified

View Trial Details

Pancreatic Neoplasms

Pancreatic Neoplasms trial results

Related conditions